Levy Elliott M. has filed 4 insider transactions across 2 companies since April 2023.
Most recent transaction: a grant/award of 37500 shares of Editas Medicine, Inc. ($EDIT) on June 06, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 6, 2025 | Editas Medicine, Inc. | $EDIT | Levy Elliott M. | Director | A | Stock Option (right to buy) | 37500 | $0.00 | 37,500.0000 | 82,976,284 | 9999.99% | 0.05% |
| June 20, 2024 | Omega Therapeutics, Inc. | $OMGAQ | Levy Elliott M. | Not found | A | Stock Option (Right to Buy) | 25000 | $0.00 | 25,000.0000 | 55,154,985 | 9999.99% | 0.05% |
| May 30, 2024 | Editas Medicine, Inc. | $EDIT | Levy Elliott M. | Director | A | Stock Option (right to buy) | 25000 | $0.00 | 25,000.0000 | 0 | 9999.99% | 0.00% |
| April 11, 2023 | Editas Medicine, Inc. | $EDIT | Levy Elliott M. | Not found | A | Stock Option (right to buy) | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |